Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-33 antibody

This Mouse Monoclonal antibody specifically detects IL-33 in WB and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN1169170
-20% for 20 Years of ABO
$253.00
$316.25
save $63.25 (-20 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 5 to 10 Business Days

Quick Overview for IL-33 antibody (ABIN1169170)

Target

See all IL-33 (IL33) Antibodies
IL-33 (IL33) (Interleukin 33 (IL33))

Reactivity

  • 92
  • 69
  • 42
  • 9
  • 1
Human

Host

  • 131
  • 36
  • 4
  • 2
  • 1
  • 1
Mouse

Clonality

  • 124
  • 51
Monoclonal

Conjugate

  • 87
  • 20
  • 15
  • 7
  • 7
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IL-33 antibody is un-conjugated

Application

  • 124
  • 84
  • 75
  • 26
  • 26
  • 25
  • 15
  • 15
  • 10
  • 8
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA

Clone

IL33068A
  • Purpose

    anti-IL-33, mAb (IL33068A)

    Specificity

    Recognizes human IL-33. Weakly cross-reacts with mouse IL-33.

    Cross-Reactivity (Details)

    Weakly cross-reacts with mouse IL-33.

    Characteristics

    Monoclonal Antibody. Recognizes human IL-33. Weakly cross-reacts with mouse IL-33. Isotype: Mouse IgG2bkappa. Clone: IL33068A. Applications: ELISA, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

    Sterility

    0.2 μm filtered

    Immunogen

    Recombinant human IL-33.

    Isotype

    IgG2b kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Preservative

    Without preservative

    Handling Advice

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    +4°C

    -20°C

    Stable for at least 1 year after receipt when stored at -20°C.

    Expiry Date

    12 months
  • Target

    IL-33 (IL33) (Interleukin 33 (IL33))

    Alternative Name

    IL-33

    Background

    Alternate Names/Synonyms: Interleukin-33, IL-1F11, NF-HEV

    Product Description: Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

    UniProt

    O95760

    Pathways

    Production of Molecular Mediator of Immune Response
You are here:
Chat with us!